Deutsche Bank
IDYA icon

Deutsche Bank’s IDEAYA Biosciences IDYA Stock Holding History

Deutsche Bank’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.83M Buy
99,568
+5,724
+6% +$216K ﹤0.01% 1412
2026
Q2 		$3.5M Sell
93,844
-284,598
-75% -$8.71M ﹤0.01% 1563
2026
Q1 		$12.6M Buy
378,442
+9,961
+3% +$334K ﹤0.01% 985
2025
Q4 		$12.7M Sell
368,481
-37,164
-9% -$1.18M ﹤0.01% 1009
2025
Q3 		$11M Sell
405,645
-9,754
-2% -$236K ﹤0.01% 1022
2025
Q2 		$8.73M Sell
415,399
-52,062
-11% -$999K ﹤0.01% 1040
2025
Q1 		$7.66M Buy
467,461
+94,482
+25% +$2.01M ﹤0.01% 1094
2024
Q4 		$9.6M Buy
372,979
+24,205
+7% +$685K ﹤0.01% 1044
2024
Q3 		$11M Buy
348,774
+13,002
+4% +$493K ﹤0.01% 988
2024
Q2 		$11.8M Buy
335,772
+30,860
+10% +$1.22M 0.01% 959
2024
Q1 		$13.4M Buy
304,912
+210,544
+223% +$9.05M 0.01% 942
2023
Q4 		$3.36M Buy
94,368
+64,459
+216% +$1.92M ﹤0.01% 1427
2023
Q3 		$807K Buy
29,909
+4,054
+16% +$103K ﹤0.01% 1869
2023
Q2 		$608K Sell
25,855
-4,230
-14% -$87K ﹤0.01% 2251
2023
Q1 		$413K Buy
30,085
+10,996
+58% +$183K ﹤0.01% 2604
2022
Q4 		$347K Buy
19,089
+3,554
+23% +$59.8K ﹤0.01% 2652
2022
Q3 		$232K Sell
15,535
-2,381
-13% -$30.9K ﹤0.01% 2863
2022
Q2 		$247K Buy
17,916
+127
+0.7% +$1.41K ﹤0.01% 3053
2022
Q1 		$199K Sell
17,789
-2,118
-11% -$31.2K ﹤0.01% 3268
2021
Q4 		$471K Buy
19,907
+1,063
+6% +$24.7K ﹤0.01% 2890
2021
Q3 		$480K Buy
18,844
+2,181
+13% +$50.9K ﹤0.01% 3065
2021
Q2 		$350K Buy
16,663
+6,335
+61% +$130K ﹤0.01% 3455
2021
Q1 		$243K Sell
10,328
-987
-9% -$19.1K ﹤0.01% 3531
2020
Q4 		$158K Buy
11,315
+3,332
+42% +$45.1K ﹤0.01% 3598
2020
Q3 		$100K Buy
7,983
+2,447
+44% +$30.3K ﹤0.01% 3547
2020
Q2 		$79K Buy
+5,536
New +$43.6K ﹤0.01% 3571

Other funds holding IDYA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
GSK plc
GSK plc London $497M AUM 35.1% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
General American Investors
General American Investors New York $1.71B AUM 30.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank's IDYA Position: Q3 2026 in Review

Deutsche Bank increased its IDEAYA Biosciences (IDYA) stake by 6.1% in Q3 2026, buying an estimated $216K and bringing the position to 99,568 shares worth $3.83M. The position accounts for ﹤0.01% of the portfolio, ranked #1412.

Deutsche Bank first reported a position in IDYA in Q2 2020 and has held it in 26 quarters since. The position peaked at $13.4M in Q1 2024. 107 funds tracked by Wall St. Rank hold IDYA as of Q3 2026.

  • Deutsche Bank held 99,568 shares of IDEAYA Biosciences worth $3.83M as of Q3 2026.
  • Deutsche Bank bought 5,724 IDEAYA Biosciences shares in Q3 2026, an estimated $216K.
  • IDEAYA Biosciences made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #1412 holding.
  • Deutsche Bank first reported a position in IDEAYA Biosciences in Q2 2020 and has held it in 26 quarters since.
  • Deutsche Bank's IDEAYA Biosciences position peaked at $13.4M in Q1 2024.
  • 107 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.